CIC
EDIT icon

Cornercap Investment Counsel’s Editas Medicine EDIT Stock Holding History

Cornercap Investment Counsel’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,906
Closed -$93K – 561
2024
Q2 		$93K Sell
19,906
-254
-1% -$1.43K 0.02% 572
2024
Q1 		$150K Buy
20,160
+146
+0.7% +$1.21K 0.02% 579
2023
Q4 		$203K Buy
+20,014
New +$176K 0.03% 530
2023
Q2 		– Sell
-11,665
Closed -$84.6K – 599
2023
Q1 		$84.6K Hold
11,665
– – 0.01% 538
2022
Q4 		$103K Hold
11,665
– – 0.02% 536
2022
Q3 		$143K Hold
11,665
– – 0.03% 516
2022
Q2 		$138K Buy
+11,665
New +$156K 0.02% 513

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cornercap Investment Counsel's EDIT Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 19,906 shares — an estimated $93K sold.

Cornercap Investment Counsel first reported a position in EDIT in Q2 2022 and held it in 7 quarters. The position peaked at $203K in Q4 2023. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 19,906 Editas Medicine shares in Q3 2024, an estimated $93K.
  • Cornercap Investment Counsel first reported a position in Editas Medicine in Q2 2022 and held it in 7 quarters.
  • Cornercap Investment Counsel's Editas Medicine position peaked at $203K in Q4 2023.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.